145 related articles for article (PubMed ID: 36961095)
1. Reduction of Platinum(IV) Prodrug Hemoglobin Nanoparticles with Deeply Penetrating Ultrasound Radiation for Tumor-Targeted Therapeutically Enhanced Anticancer Therapy.
Liang G; Sadhukhan T; Banerjee S; Tang D; Zhang H; Cui M; Montesdeoca N; Karges J; Xiao H
Angew Chem Int Ed Engl; 2023 May; 62(22):e202301074. PubMed ID: 36961095
[TBL] [Abstract][Full Text] [Related]
2. Photo-Reduction with NIR Light of Nucleus-Targeting Pt
Wei D; Huang Y; Wang B; Ma L; Karges J; Xiao H
Angew Chem Int Ed Engl; 2022 May; 61(20):e202201486. PubMed ID: 35212437
[TBL] [Abstract][Full Text] [Related]
3. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer.
Wang Y; Luo Z; Zhou D; Wang X; Chen J; Gong S; Yu Z
Biomater Sci; 2021 Jun; 9(11):4110-4119. PubMed ID: 33949442
[TBL] [Abstract][Full Text] [Related]
4. Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment.
Wang Z; Deng Z; Zhu G
Dalton Trans; 2019 Feb; 48(8):2536-2544. PubMed ID: 30633263
[TBL] [Abstract][Full Text] [Related]
5. Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo.
Xiao H; Noble GT; Stefanick JF; Qi R; Kiziltepe T; Jing X; Bilgicer B
J Control Release; 2014 Jan; 173():11-7. PubMed ID: 24511610
[TBL] [Abstract][Full Text] [Related]
6. Endowing Pt(IV) with Perfluorocarbon Chains and Human Serum Albumin Encapsulation for Highly Effective Antitumor Chemoimmunotherapy.
Xie P; Jin Q; Zhang L; Zhang H; Montesdeoca N; Karges J; Xiao H; Mao X; Song H; Shang K
ACS Nano; 2024 May; 18(21):13683-13695. PubMed ID: 38749906
[TBL] [Abstract][Full Text] [Related]
7. Enhancing Circulation and Tumor Accumulation of Carboplatin via an Erythrocyte-Anchored Prodrug Strategy.
Yao H; Wang Z; Wang N; Deng Z; Liu G; Zhou J; Chen S; Shi J; Zhu G
Angew Chem Int Ed Engl; 2022 Jun; 61(25):e202203838. PubMed ID: 35352863
[TBL] [Abstract][Full Text] [Related]
8. Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
Gibson D
J Inorg Biochem; 2021 Apr; 217():111353. PubMed ID: 33477089
[TBL] [Abstract][Full Text] [Related]
9. Photoinduced Reduction of Novel Dual-Action Riboplatin Pt(IV) Prodrug.
Krasnovskaya OO; Akasov RA; Spector DV; Pavlov KG; Bubley AA; Kuzmin VA; Kostyukov AA; Khaydukov EV; Lopatukhina EV; Semkina AS; Vlasova KY; Sypalov SA; Erofeev AS; Gorelkin PV; Vaneev AN; Nikitina VN; Skvortsov DA; Ipatova DA; Mazur DM; Zyk NV; Sakharov DA; Majouga AG; Beloglazkina EK
ACS Appl Mater Interfaces; 2023 Mar; 15(10):12882-12894. PubMed ID: 36854172
[TBL] [Abstract][Full Text] [Related]
10. An ultrasound-activatable platinum prodrug for sono-sensitized chemotherapy.
Liu G; Zhang Y; Yao H; Deng Z; Chen S; Wang Y; Peng W; Sun G; Tse MK; Chen X; Yue J; Peng YK; Wang L; Zhu G
Sci Adv; 2023 Jun; 9(25):eadg5964. PubMed ID: 37343091
[TBL] [Abstract][Full Text] [Related]
11. Alendronate Pt
Sun K; Yuan L; Chen S; Sun Y; Wei D
Adv Healthc Mater; 2024 Mar; 13(7):e2302746. PubMed ID: 37988194
[TBL] [Abstract][Full Text] [Related]
12. BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity.
Yao H; Chen S; Deng Z; Tse MK; Matsuda Y; Zhu G
Inorg Chem; 2020 Aug; 59(16):11823-11833. PubMed ID: 32799491
[TBL] [Abstract][Full Text] [Related]
13. Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
Li Y; Deng Y; Tian X; Ke H; Guo M; Zhu A; Yang T; Guo Z; Ge Z; Yang X; Chen H
ACS Nano; 2015 Oct; 9(10):9626-37. PubMed ID: 26365698
[TBL] [Abstract][Full Text] [Related]
14. A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastoma.
Jimenez-Macias JL; Lee YC; Miller E; Finkelberg T; Zdioruk M; Berger G; Farquhar CE; Nowicki MO; Cho CF; Fedeles BI; Loas A; Pentelute BL; Lawler SE
J Control Release; 2022 Dec; 352():623-636. PubMed ID: 36349615
[TBL] [Abstract][Full Text] [Related]
15. The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022.
Su S; Chen Y; Zhang P; Ma R; Zhang W; Liu J; Li T; Niu H; Cao Y; Hu B; Gao J; Sun H; Fang D; Wang J; Wang PG; Xie S; Wang C; Ma J
Eur J Med Chem; 2022 Dec; 243():114680. PubMed ID: 36152386
[TBL] [Abstract][Full Text] [Related]
16. NIR-II Light Accelerated Prodrug Reduction of Pt(IV)-Incorporating Pseudo Semiconducting Polymers for Robust Degradation and Maximized Photothermal/Chemo-Immunotherapy.
Tang D; Zhou H; Cui M; Liang G; Zhang H; Xiao H
Adv Mater; 2023 Jul; 35(28):e2300048. PubMed ID: 37016274
[TBL] [Abstract][Full Text] [Related]
17. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
[TBL] [Abstract][Full Text] [Related]
18. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.
Datta P; Bang S; Yue Z; Beach T; Stilgenbauer M; Wang H; Bowers DJ; Kurokawa M; Xiao H; Zheng YR
Dalton Trans; 2020 Jun; 49(24):8107-8113. PubMed ID: 32490446
[TBL] [Abstract][Full Text] [Related]
19. Reduction-sensitive platinum (IV)-prodrug nano-sensitizer with an ultra-high drug loading for efficient chemo-radiotherapy of Pt-resistant cervical cancer in vivo.
Luo K; Guo W; Yu Y; Xu S; Zhou M; Xiang K; Niu K; Zhu X; Zhu G; An Z; Yu Q; Gan Z
J Control Release; 2020 Oct; 326():25-37. PubMed ID: 32531414
[TBL] [Abstract][Full Text] [Related]
20. Supramolecular platinum complexes for cancer therapy.
Jogadi W; Zheng YR
Curr Opin Chem Biol; 2023 Apr; 73():102276. PubMed ID: 36878171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
